dorsaVi Says Testing of Biomedical Sensors Shows RRAM Integration Improves Write Speeds, Ultra-Low-Power Operations

MT Newswires Live
2025/07/22

dorsaVi (ASX:DVL) said that an internal evaluation of RRAM-enabled biomedical sensors, conducted in Singapore, showed that Resistive Random Access Memory (RRAM) integration delivered significant gains, including up to 50 times faster write speeds, over 5,000 times faster read access, and over 10 million endurance cycles under biosignal workloads, compared with the current flash memory system, according to a Tuesday Australian bourse filing.

Ultra-low-power operation was validated, with under 200 picojoules-per-bit write energy supporting extended device uptime and smaller battery requirements.

The performance was observed in real-time electromyography and electrocardiography conditions, supporting enhanced signal tagging, processing accuracy, and clinical reliability.

Its shares rose 9% on market close.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10